Evidence map›Paper›PMID 38151903›Full record

ArticleCancer medicine2024

Association of neighborhood gentrification with prostate cancer and immune markers in African American and European American men.

Catherine M Pichardo, Adaora Ezeani, Margaret S Pichardo, Tanya Agurs-Collins, Tiffany M Powell-Wiley, Brid Ryan, Tsion Zewdu Minas, Maeve Bailey-Whyte, Wei Tang, Tiffany H Dorsey and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Catherine M PichardoDivision of Cancer Control and Population Sciences, NCI, NIH, Rockville, Maryland, USA.
Adaora EzeaniDivision of Cancer Control and Population Sciences, NCI, NIH, Rockville, Maryland, USA.
Margaret S PichardoDepartment of Surgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9132-4400
Tanya Agurs-CollinsDivision of Cancer Control and Population Sciences, NCI, NIH, Rockville, Maryland, USA.
Tiffany M Powell-WileySocial Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, Bethesda, Maryland, USA.
Brid RyanLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Tsion Zewdu MinasLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Maeve Bailey-WhyteLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Wei TangLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Tiffany H DorseyLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.
William WootenUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Biostatistics Shared Service, Baltimore, Maryland, USA.
Christopher A LoffredoCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA.
Stefan AmbsLaboratory of Human Carcinogenesis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.ORCID 0000-0001-7651-9309
National Institutes of Health · USNational Cancer Institute · USGeorgetown University · USHospital of the University of Pennsylvania · USUniversity of Maryland, Baltimore · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Maryland Prostate Cancer Case-Control StudyZIABC010499 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI AMBS, STEFAN · 2009 to 2025
$11.4M
Tailoring Mobile Health Technology to Reduce Obesity and ImproveCardiovascular Health in Resource-Limited Neighborhood Environments: A Multi-Level, Community-Based Physical Activity InterventionZIAHL006225 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI POWELL-WILEY, TIFFANY · 2017 to 2025
$9.7M
Cardiovascular Health and Needs Assessment in Washington D.C.ZIAHL006168 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI POWELL-WILEY, TIFFANY · 2013 to 2025
$8.1M
The Molecular Profile of Prostate Tumors in African-American MenZIABC010624 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI AMBS, STEFAN · 2009 to 2025
$8.0M
Pilot Study for Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in WomenZIAHL006252 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI POWELL-WILEY, TIFFANY · 2020 to 2025
$5.7M
NIMHD Adjunct Investigator ProgramZIJMD000010 · NIMHD · NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES · PI CHOI, KELVIN · 2017 to 2025
$3.4M
Intramural NIH HHS ZIA BC010499Intramural NIH HHS ZIA BC010624Intramural NIH HHS ZIA HL006168Intramural NIH HHS ZIA HL006225Intramural NIH HHS ZIA HL006252Intramural NIH HHS ZIJ MD000010Intramural Research Program of the NIH, National Cancer Institute (NCI), Center for Cancer Research ZIA BC 010499, 010624 to S.A.NCI NIH HHS P30 CA051008NHLBI Division of Intramural Research ZIA HL006168 to T.M.P.W.NHLBI Division of Intramural Research ZIA HL006225 to T.M.P.W.NHLBI Division of Intramural Research ZIA HL006252 to T.M.P.W.NIMHD NIH HHS ZIJ MD000010 to T.M.P.W.U.S. Department of Defense W81XWH1810588 to S.A.
6 · The paper itself

Abstract

backgroundPrior studies showed that neighborhood deprivation increases the risk of lethal prostate cancer. However, the role of neighborhood gentrification in prostate cancer development and outcome remains poorly understood. We examined the relationships of gentrification with prostate cancer and serum proteome-defined inflammation and immune function in a diverse cohort.

methodsThe case-control study included 769 cases [405 African American (AA), 364 European American (EA) men] and 1023 controls (479 AA and 544 EA), with 219 all-cause and 59 prostate cancer-specific deaths among cases. Geocodes were linked to a neighborhood gentrification index (NGI) derived from US Census data. Cox and logistic regression, and MANOVA, were used to determine associations between NGI, as continuous or quintiles (Q), and outcomes.

resultsAdjusting for individual socioeconomic status (SES), continuous NGI was positively associated with prostate cancer among all men (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.01-1.14). AA and low-income men experienced the highest odds of prostate cancer when residing in tracts with moderate gentrification, whereas EA men experienced reduced odds of regional/metastatic cancer with increased gentrification in SES-adjusted analyses. Continuous NGI also associated with mortality among men presenting with localized disease and low-income men in SES-adjusted Cox regression analyses. NGI was not associated with serum proteome-defined chemotaxis, inflammation, and tumor immunity suppression.

conclusionsFindings show that neighborhood gentrification associates with prostate cancer and mortality in this diverse population albeit associations were heterogenous within subgroups. The observations suggest that changing neighborhood socioeconomic environments may affect prostate cancer risk and outcome, likely through multifactorial mechanisms.

Indexed as

Black or African AmericanProstatic NeoplasmsWhiteAgedBiomarkers, TumorCase-Control StudiesHumansMaleMiddle AgedNeighborhood CharacteristicsResidence CharacteristicsResidential SegregationRisk FactorsUnited StatesBiomarkers, Tumorhealth disparityimmune markersminority and vulnerable populationsmortalityneighborhoodprostate cancer

Identifiers

PMID38151903
PMCPMC10807554
OpenAlexW4390343979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.